Meditus

Acetylcysteine, the active ingredient in Meditus, is a mucolytic agent presented as an oral formulation for oral use. It helps reduce the thickness of mucus in respiratory conditions such as chronic bronchitis, COPD and cystic fibrosis. GNH USA supplies Meditus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Acetylcysteine acts on the respiratory mucus pathway to improve clearance of thick secretions. - Chronic bronchitis: loosens and clears viscous mucus, facilitating expectoration. - Chronic obstructive pulmonary disease (COPD): reduces mucus viscosity, aiding breathing comfort. - Cystic fibrosis: helps clear airway secretions, supporting pulmonary function.

Acetylcysteine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools may appear. - Abdominal discomfort: cramping or pain in the stomach area. - Rash: skin redness or itching. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty. - Stevens‑Johnson syndrome: rare severe skin eruption. - Bronchospasm: sudden narrowing of airways. - Hepatic dysfunction: abnormal liver enzyme elevations. - Neutropenia: low white‑blood‑cell count. - Angioedema: swelling of face, lips or tongue.

When using Acetylcysteine, consider the following safety measures. - Renal impairment: use with caution in patients with severe kidney disease. - Asthma: monitor for possible bronchospasm during therapy. - Pregnancy: safety not established; prescribe only if benefit outweighs risk. - Drug interactions: review all concomitant medications for potential effects. - Overdose: seek immediate medical attention if excessive amount is taken. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Acetylcysteine may interact with several medicines; awareness helps avoid complications.

Major Interactions (Avoid): - Nitroglycerin: concurrent use may cause marked hypotension. - Activated charcoal: can reduce acetylcysteine absorption if given together. - Anticholinergic agents: may diminish the mucolytic effect.

Moderate Interactions (Monitor Closely): - Penicillins and other antibiotics: increased risk of rash. - Warfarin: possible alteration of INR values. - Corticosteroids: may raise risk of gastrointestinal irritation.